GB8826298D0 - Production of lak cells compositions containing them & their use in cancer therapy - Google Patents

Production of lak cells compositions containing them & their use in cancer therapy

Info

Publication number
GB8826298D0
GB8826298D0 GB888826298A GB8826298A GB8826298D0 GB 8826298 D0 GB8826298 D0 GB 8826298D0 GB 888826298 A GB888826298 A GB 888826298A GB 8826298 A GB8826298 A GB 8826298A GB 8826298 D0 GB8826298 D0 GB 8826298D0
Authority
GB
United Kingdom
Prior art keywords
production
compositions containing
cancer therapy
lak cells
cells compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB888826298A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Byrne P M O
Williams N S
Original Assignee
Byrne P M O
Williams N S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byrne P M O, Williams N S filed Critical Byrne P M O
Priority to GB888826298A priority Critical patent/GB8826298D0/en
Publication of GB8826298D0 publication Critical patent/GB8826298D0/en
Priority to GB8925435A priority patent/GB2225021A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A61K38/2013—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/31—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterized by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2239/00—Indexing codes associated with cellular immunotherapy of group A61K39/46
    • A61K2239/46—Indexing codes associated with cellular immunotherapy of group A61K39/46 characterised by the cancer treated
    • A61K2239/49—Breast

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB888826298A 1988-11-10 1988-11-10 Production of lak cells compositions containing them & their use in cancer therapy Pending GB8826298D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB888826298A GB8826298D0 (en) 1988-11-10 1988-11-10 Production of lak cells compositions containing them & their use in cancer therapy
GB8925435A GB2225021A (en) 1988-11-10 1989-11-10 The production of LAK cells, compositions containing them, and their use

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888826298A GB8826298D0 (en) 1988-11-10 1988-11-10 Production of lak cells compositions containing them & their use in cancer therapy

Publications (1)

Publication Number Publication Date
GB8826298D0 true GB8826298D0 (en) 1988-12-14

Family

ID=10646628

Family Applications (2)

Application Number Title Priority Date Filing Date
GB888826298A Pending GB8826298D0 (en) 1988-11-10 1988-11-10 Production of lak cells compositions containing them & their use in cancer therapy
GB8925435A Withdrawn GB2225021A (en) 1988-11-10 1989-11-10 The production of LAK cells, compositions containing them, and their use

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB8925435A Withdrawn GB2225021A (en) 1988-11-10 1989-11-10 The production of LAK cells, compositions containing them, and their use

Country Status (1)

Country Link
GB (2) GB8826298D0 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4690915A (en) * 1985-08-08 1987-09-01 The United States Of America As Represented By The Department Of Health And Human Services Adoptive immunotherapy as a treatment modality in humans
CA1300058C (en) * 1987-01-29 1992-05-05 Joseph D. Irr Process for preparing activated killer cells

Also Published As

Publication number Publication date
GB2225021A (en) 1990-05-23
GB8925435D0 (en) 1989-12-28

Similar Documents

Publication Publication Date Title
IL83012A0 (en) Immunoconjugates for use in tumor therapy and their production
GB2193631B (en) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
GB2157172B (en) Improvements in or relating to interleukin therapy
GB8701900D0 (en) Expression of genes in plants
ZA836222B (en) Compositions and their use in the production of dental restorations
EP0172721A3 (en) Use of phlorizin or its derivatives in the treatment of cancer
ZA872768B (en) Enhanced expression of human interleukin-2 in mammalian cells
PT78986B (en) Coumarin derivatives pharmaceutical compositions containing the same and use thereof in the treatment of cancer
GB8821268D0 (en) Improvements in & relating to manufacture of laminates
HUT55990A (en) Process for producing pharmaceutical compositions containing optically pure r-(-)-niguldipine and derivatives utilizable for treating tumors
ZA875268B (en) Stable pharmaceutical preparation containing granulocyte colony stimulating factor and process for producing the same
GR870093B (en) 8a- acylaminoergolines their production and pharmaceutical compositions containing them
DE3565212D1 (en) Pharmaceutical drug carrier in the form of an anhydrous gel
GB8826298D0 (en) Production of lak cells compositions containing them & their use in cancer therapy
GB8802952D0 (en) Compositions for use in treatment of cellulosic materials & their preparation
DE3663036D1 (en) Phosphonic-acid derivatives for use as adjuvants in leather manufacture
EP0409901A4 (en) Lak cell cytotoxin
GB8814476D0 (en) Production of cosmetic/pharmaceutical composition
AU555018B2 (en) Efficiency improvement of in vitro tissue cultivation
GB8826453D0 (en) Use of lak cells
GB8819626D0 (en) Pharmaceutical composition for treatment of tumours
IL75907A0 (en) In vitro production of human ypsilon-interferon
IL79321A0 (en) In vitro production of human ypsilon-interferon
ZM6386A1 (en) Novel benzodioxepanne process for the synthesis there of and uses thereof in therapeutics
IL81767A0 (en) In vitro production of human epsilon-interferon